Fig. 4
From: Targeting KRAS mutant cancers: from druggable therapy to drug resistance
The schematic diagram of FAK-YAP axis affecting efficacy of KRAS (G12C) inhibitor
Fig. 4 | Molecular Cancer
From: Targeting KRAS mutant cancers: from druggable therapy to drug resistance
The schematic diagram of FAK-YAP axis affecting efficacy of KRAS (G12C) inhibitor
Molecular Cancer